Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Eriksson Faelker TM"'
Autor:
Ricke KM; Center for Physiology and Pathophysiology, Institute of Vegetative Physiology, rudolf.wiesner@uni-koeln.de kricke@uottawa.ca., Paß T; Center for Physiology and Pathophysiology, Institute of Vegetative Physiology., Kimoloi S; Center for Physiology and Pathophysiology, Institute of Vegetative Physiology., Fährmann K; Center for Physiology and Pathophysiology, Institute of Vegetative Physiology., Jüngst C; Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases (CECAD)., Schauss A; Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases (CECAD)., Baris OR; Center for Physiology and Pathophysiology, Institute of Vegetative Physiology., Aradjanski M; Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases (CECAD).; Institute for Mitochondrial Diseases and Aging, Medical Faculty, and., Trifunovic A; Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases (CECAD).; Institute for Mitochondrial Diseases and Aging, Medical Faculty, and.; Center for Molecular Medicine Cologne, University of Köln, 50931 Köln, Germany., Eriksson Faelker TM; Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases (CECAD)., Bergami M; Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases (CECAD).; Center for Molecular Medicine Cologne, University of Köln, 50931 Köln, Germany., Wiesner RJ; Center for Physiology and Pathophysiology, Institute of Vegetative Physiology, rudolf.wiesner@uni-koeln.de kricke@uottawa.ca.; Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases (CECAD).; Center for Molecular Medicine Cologne, University of Köln, 50931 Köln, Germany.
Publikováno v:
The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2020 Feb 26; Vol. 40 (9), pp. 1975-1986. Date of Electronic Publication: 2020 Jan 31.
Autor:
Himmel HM; Safety Pharmacology, Bayer AG, Aprather Weg 18a, 42096 Wuppertal, Germany. Electronic address: herbert.himmel@bayer.com., Delaunois A; UCB Biopharma SPRL, chemin du Foriest, 1420 Braine-l'Alleud, Belgium. Electronic address: Annie.Delaunois@ucb.com., Deurinck M; Novartis Institutes of Biomedical Research, Novartis Pharma AG, PO Box CH-4002, Basel, Switzerland. Electronic address: mark.deurinck@novartis.com., Dinklo T; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Eriksson Faelker TM; Safety Pharmacology, Bayer AG, Aprather Weg 18a, 42096 Wuppertal, Germany. Electronic address: therese.erikssonfaelker@bayer.com., Habermann C; Grünenthal Innovation, Grünenthal GmbH, D-52078 Aachen, Germany. Electronic address: christopher.habermann@grunenthal.com., Heers C; Merz Pharmaceuticals GmbH, Alfred-Wegener-Str. 2, 60438 Frankfurt (Main), Germany. Electronic address: Cara.Heers@merz.de., Hempel K; Dept. Preclin. Safety, AbbVie Deutschland GmbH & Co. KG, Knollstr., 67061 Ludwigshafen, Germany. Electronic address: katja.hempel@abbvie.com., Lorenz H; Dept. Preclin. Safety, AbbVie Deutschland GmbH & Co. KG, Knollstr., 67061 Ludwigshafen, Germany. Electronic address: helga.lorenz@abbvie.com., Rosch A; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397 Biberach, Germany. Electronic address: anke.rosch@boehringer-ingelheim.com., Schauerte H; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397 Biberach, Germany. Electronic address: heike.schauerte@boehringer-ingelheim.com., Teuns G; Janssen, Global Safety Pharmacology, Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium. Electronic address: GTEUNS@its.jnj.com., Traebert M; Novartis Institutes of Biomedical Research, Novartis Pharma AG, PO Box CH-4002, Basel, Switzerland. Electronic address: martin.traebert@novartis.com., van Amsterdam C; Merck, Global Non Clinical Safety, Frankfurter Str. 250, 64293 Darmstadt, Germany. Electronic address: Christoph.vanAmsterdam@merckgroup.com., van der Linde H; Janssen, Global Safety Pharmacology, Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium. Electronic address: HVDLINDE@its.jnj.com.
Publikováno v:
Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2019 Sep - Oct; Vol. 99, pp. 106571. Date of Electronic Publication: 2019 Mar 27.
Autor:
Himmel HM; Bayer AG, Safety Pharmacology, Aprather Weg 18a, 42096 Wuppertal, Germany. Electronic address: herbert.himmel@bayer.com., Eriksson Faelker TM; Bayer AG, Safety Pharmacology, Aprather Weg 18a, 42096 Wuppertal, Germany. Electronic address: therese.erikssonfaelker@bayer.com.
Publikováno v:
Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2019 Sep - Oct; Vol. 99, pp. 106588. Date of Electronic Publication: 2019 May 28.